Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. The unwarranted effects of medications used in psychiatry can adversely affect a treatment plan. This book is critical in helping psychiatrists and mental health professionals assess the adverse effects of drugs such as antidepressants, mood stabilizers, hypnosedatives, and antipsychotic drugs.The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler's Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used.This volume is critical for any health professional involved in the administration of psychiatric mediations.
Aronson
Meyler's Side Effects of Psychiatric Drugs jetzt bestellen!
Zielgruppe
Psychiatrists and mental health professionals
Weitere Infos & Material
PrefaceAntidepressantsTricyclic AntidepressantsSelective Serotonin Re-uptake Inhibitors (SSRIS)Monoamine Oxidase InhibitorsOther AntidepressantsLithium Neuroleptic DrugsHypnosedativesBenzodiazepinesNon-benzodiazepine HypnosedativesDrugs of AbuseAmphetaminesCannabinoidsCocaineDexamfetamineDiamorphine (Heroin)DimethyltryptamineGammahydroxybutyrateKhatLysergideMescalineMetamfetamineMethadoneMethylenedioxymetamfetamine (MDMA, Ecstasy)Organic SolventsPhencyclidinePsilocybinDrugs Used in Alzheimer's Disease 629Psychological and Psychiatric Adverse Effects of Non-psychoactive DrugsIndex of Drug Names
Aronson, Jeffrey K.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.
